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defined. Type 1 is produced by all Streptococcus zymogenes (S. faecali.8 var. zymogenes) strains, is active against a wide variety of gram-positive bacteria, and is also a hemolysin. Type 2 is produced by some S. liquefaciens (S. faecalis var. liquefaciens) strains, and acts on many enterococci as well as on certain other lactic acid bacteria. Type 3 is produced by certain strains of both S. faecalis and S. faecium, and inhibits a wide variety of group D streptococci, but is inactive against all other lactic acid bacteria tested except Leuconostoc citrovorum. Type 4 is produced by certain S. faecium strains and resembles in certain ways the type 3 activity, but differs from it in other ways. Type 5 has been found to be produced by only one proteolytic strain of S. zymogenes, and this bacteriocine has a very narrow spectrum. The strain that produces this bacteriocine also produces type 1 activity. No strain is sensitive to a bacteriocine of the type it produces.
In surveys of bacterial strains for lysogeny, a by-product of the research is frequently the discovery of antibiotic substances (or bacteriocines) produced by certain strains which are active against other strains. These substances differ from classical antibiotics in (i) the narrowness of their spectrums, (ii) their action on strains IU.S. Public Health Service Research Career Development Awardee, grant 403. 2National Science Foundation Undergraduate Research Participant. closely related to the producer, and (iii) their chemical complexity. To date, antibiotics of this sort have been detected in a wide variety of bacteria (reviewed by Fredericq, 1957; Ivanovics, 1962; Hamon and Peron, 1963) .
Preliminary detection of bacteriocines in group D streptococci was made by Kjems (1955) and Pohonek (1961) , and Brandis and Brandis (1962) made a detailed characterization of one of the bacteriocines detected by Kjems. Further, DeKlerk and Coetzee (1961) observed bacteriocines in lactobacilli that seem to be related to those of the enterococci.
The present work represents a survey of bacteriocine production by a wide variety of wellcharacterized strains. It is shown that at least five different bacteriocines are produced by various strains of enterococci, and the association of bacteriocine type with other taxonomic characters is considered. It is also shown that certain of these bacteriocines are able to act on other lactic acid bacteria as well as on some bacteria more distantly related. In an accompanying paper, a detailed study of the bacteriocine produced by the hemolytic enterococci is presented, and the probable identity of this bacteriocine with the hemolysin will be demonstrated. An underlying question, unanswered by these studies, is what role bacteriocines play in the life of bacteria.
MATERALS AND METHODS
Organisms. A wide variety of enterococci obtained from various culture collections were used. Not all of the strains examined will be mentioned explicitly; the ones used most frequently are listed in Table 1 . The nomenclature of these strains follows Skadhauge (1950) , Barnes (1956) , and Shattock (1955) , and the kety diagnostic characteristics associated with the species epithets are given in Table 2 . The organisms were all grown in Todd-Hewitt broth or agar (Difco).
Bacteriocine test procedure. Overnight broth cultures of the strains were inoculated by loop onto the surface of agar plates, five or six strains per plate, and the plates were incubated 18 to 24 hr at 37 C. At this time, 2 ml of 0.75% agar, to which 0.1 ml of an indicator strain in the late exponential phase of growth had been added, were poured on the surface of the plate; the plate was again incubated at 37 C for 6 to 8 hr, at which time the indicator had fully grown and the zones of inhibition could be seen. The distance from the outer edge of the colony of the bacteriocine producer to the edge of the inhibition zone was Table 2 , and included both bacteriocine producers and strains that appeared not to produce bacteriocines. The bacteriocines were then characterized further by determining their sensitivity to chloroform, heat, and proteolytic enzymes. From these results, the bacteriocines could be divided into five types (Table 3) .
A detailed study of Table 3 reveals a number of interesting points.
(i) A strain is always resistant to its own bacteriocine and to that produced by others of its type.
(ii) A bacteriocine producer may be sensitive to bacteriocines of other types.
(iii) All bacteriocines of the same type show the same behavior to heat, chloroform, and protease.
(iv) Bacteriocines of S. zymogenes (S. faecalis var. zymogenes) and S. liquefaciens (S. faecalis var. liquefaciens) types are resistant to protease action, whereas those of S. faecium and S. faecalis types are sensitive.
(v) All strains of S. zymogenes produce a bacteriocine which is a hemolysin (see accompanying paper) and which is chloroform-sensitive. This bacteriocine is active against all enterococci except S. zymogenes.
(vi) Strain X74, which is hemolytic and produces a type 1 bacteriocine, also produces an additional bacteriocine which is active against other S. zymogenes strains and which differs from all the other bacteriocines. The two bacteriocines of X74 could be distinguished because the type 1 bacteriocine is active against X13 but not against X14 and is chloroform-sensitive, whereas the type 5 bacteriocine is active against X14 but not against X13 and is chloroformresistant. (vii) Although all S. liquefaciens strains that produce a bacteriocine produce one of the same type (viz., X21, 33, 52, 82) , not all S. liquefaciens strains produce a bacteriocine (viz., X4). However, all S. liquefaciens strains (as well as S. zymogenes strains) are resistant to this type 2 bacteriocine, whether or not they produce it. This bacteriocine is active against all S. faecium strains tested and some, but not all, S. faecalis strains.
(viii) Type 3 bacteriocine is produced by some strains of S. faecium and S. faecalis, but only a very few (4 of 40 strains tested), and this bacteriocine is active against all S. zymogenes and S. liquefaciens strains as well as against some S. faecium and S. faecalis strains. It inhibits more group D strains than any of the other bacteriocines, and gives the largest zones. In its properties, it seems to resemble the bacteriocine studied by Brandis and Brandis (1962) .
(ix) Type 4 bacteriocine is produced by only two S. faecium strains (of about 15 strains tested). This bacteriocine is active against some S. faecium and S. faecalis strains (viz., X3, X46) and not others (X13, X18, X47), but is active against all S. zymogenes and S. liquefaciens strains. Note that type 4 producers and type 3 producers do not always exhibit reciprocal cross resistance, even though certain strains in each group are cross-resistant with those of the other group. Thus, type 3 strains X18 and X47 are resistant to type 4, but X56 (also type 3) is sensitive. The bacteriocines studied by Kjems (1955) than group D streptococci, except for Leuconostoc citrovorum. And, finally, the type 5 bacteriocine affects none of these bacteria, and its action seems to be restricted to group D streptococci only. Note, however, that the type 3 bacteriocine is active against most strains of group D streptococci. This is, then, the bacteriocine most likely to be of use in taxonomic studies with group D streptococci, and its action against L. citrovorum would encourage speculation on a close relationship between this organism and the group D streptococci.
We thus see that the group D streptococcus bacteriocines present an extremely diverse picture when viewed from their action on gram-positive bacteria.
DISCUSSION
The overall impression the reader will gain from the above work is that the situation is confused. Unfortunately, there is no reason to think that future work will make things simpler, because it is likely that a detailed study of the bacteriocines in any one type will reveal that each type is really a mixture of subtypes. Thus, the results presented here may inhibit rather than encourage further work. When it is realized that of the almost 100 strains tested over 50% produced one bacteriocine or another, it is clear that these bacteria are endowed with a mysterious but widespread property. It is safe to assume that these bacteria do not produce these substances accidentally, but that a bacteriocine plays some role in the life of the organism.
The only group of strains which exhibit any uniformity are the hemolytic S. zymogenes strains, but, since the bacteriocine and hemolvsin activities of these organisms are probably due to the same substance, this uniformity is understandable; we are categorizing strains as S. zymogenes by their hemolytic character, and this automatically (if the identity of the hemolysin and bacteriocine is accepted) makes them uniform in regard to the bacteriocine. Note, however, that S. durans strains, which are hemolytic, do not produce a bacteriocine; this observation further emphasizes the differences between S. zymogenes and S. durans. Hamon and Peron (1963) considered briefly the function of bacteriocines, and concluded that they probably serve as fertility factors. Although it is true that cell-to-cell contact is mediated in some enteric bacteria by bacteriocines, there is no prior reason why this should be so in all kinds of bacteria. If this idea is correct, however, it is clear that we have at hand a simple method of determining sexual compatibilities between strains. Our current efforts will therefore be to see whether we can obtain any evidence of genetic recombination between some of the strains listed in Table 3 . Results to date with strain X14 have been negative.
Another role for bacteriocines is in invasion of a host. Hamon and Peron (1963) rejected this idea, but Pohonek (1961) postulated that streptococci which produce bacteriocines that attack vaginal lactobacilli may be able, because of this property, to invade the vagina and replace the resident bacteria. A similar idea is discussed in the accompanying paper for the S. zymogenes strains.
The enterococcus taxonomist, looking at Table 3 , will lose no time in concluding that bacteriocinogeny will be of little value in delineating the grand design of the enterococcus group. Since bacteriophage typing is also of little value in this regard (Brock, unpublished data), and since serology (Sharpe and Shattock, 1952) has been similarly disappointing, we may be left with the notion that various strains of enterococci in reality have very little in common, and represent a group of organisms so diverse that no grand design exists.
The production of antibiotics of the nisin type by strains of S. lactis may be an analogous phenomenon to that reported here. Like nisin, the enterococcus bacteriocines act on certain other gram-positive bacteria, and the types 3 and 4 described here may be structurally similar to nisin (see, for instance, Brandis and Brandis, 1962) . However, the type 1, type 2, and type 5 bacteriocines, which are insensitive to proteolytic action, and especially type 1, which is chloroform-sensitive, differ markedly from the nisin type. Indeed, type 1 bacteriocine may represent a new type of antibacterial agent.
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